To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Biotie TherapiesBiotie Therapies (OMX: BTH1V) is a Finnish biotechnology and pharmaceutics company. The company's research and development is focused on dependence disorders, inflammatory diseases and thrombosis. The company's headquarter is located in Turku, Western Finland, and it is listed on Helsinki Stock Exchange. Additional recommended knowledgeBiotie Therapies was formed in the merger of Biotie Therapies Corp., Oy Contral Pharma Ltd and its subsidiary Carbion Inc in the year 2002. In the year 2006 the company generated revenue of 1,12 million euros. |
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Biotie_Therapies". A list of authors is available in Wikipedia. |
Last viewed
- L'enseignement en ligne déclenche une réponse différente dans le corps
- Occlusion_(dentistry)
- Journal_of_the_Norwegian_Medical_Association
- Modèles complexes : construire un pont entre les grands et les petits modèles - Une nouvelle théorie permet de simuler la formation de motifs complexes dans les systèmes biologiques à différentes échelles spatiales et temporelles.
